Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures

被引:9
|
作者
Hogfeldt, Therese [1 ]
Bahnassy, Abeer A. [2 ]
Kwiecinska, Anna [5 ,6 ]
Osterborg, Anders [1 ,7 ]
Tamm, Katja Pokrovskaja [1 ]
Porwit, Anna [8 ]
Zekri, Abdel-Rahman N. [3 ]
Lundahl, Joachim [9 ]
Khaled, Hussein M. [4 ]
Mellstedt, Hakan [1 ]
Moshfegh, Ali [1 ]
机构
[1] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[2] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt
[3] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Cairo, Egypt
[4] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
[5] Karolinska Inst, Dept Pathol, S-10401 Stockholm, Sweden
[6] Karolinska Univ Hosp Solna, SE-17176 Stockholm, Sweden
[7] Karolinska Univ Hosp Solna, Dept Hematol, SE-17176 Stockholm, Sweden
[8] Univ Hlth Network, Toronto Gen Hosp, Dept Lab Hematol, Toronto, ON, Canada
[9] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Diffuse large B-cell lymphoma; gene expression; inflammation; STAT; viral infections; NON-HODGKINS-LYMPHOMA; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; RECEPTOR TYROSINE KINASE; LYMPHOPROLIFERATIVE DISORDERS; HEPATOCELLULAR-CARCINOMA; DEVELOPING-COUNTRIES; RISK-FACTORS; EXPRESSION; CANCER;
D O I
10.3109/10428194.2012.738365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with an association with inflammation and viral infections. We hypothesize that environmental factors may be involved in the pathogenesis of DLBCL. In this study, we compared gene expression profiles of lymph node tissues from patients with DLBCL from two different geographical areas with diverse environmental exposures. Specimens from Egyptian and Swedish patients with DLBCL as well as controls were studied. Gene expression analysis using microarray and quantitative polymerase chain reaction demonstrated significantly higher expression of signal transducer and activator of transcription 3 (STAT3) in Swedish as compared to Egyptian patients and control materials from both countries. This was confirmed at protein level using confocal microscopy. The receptor tyrosine kinase ROR1, a "survival factor" for malignant cells, was overexpressed and significantly related to the STAT3 expression pattern. The difference in the expression of genes involved in inflammatory responses and in the tumorigenic process of DLBCL might relate to infectious agents and/or other environmental exposures.
引用
收藏
页码:996 / 1003
页数:8
相关论文
共 50 条
  • [21] DETECTION OF BONE MARROW B-CELL CLONALITY IN DIFFUSE LARGE B-CELL LYMPHOMA
    Gavrilina, O. A.
    Zvonkov, E. E.
    Sudarikov, A. B.
    Nikulina, E. E.
    Sidorova, Yu, V
    Biderman, B., V
    Kovrigina, A. M.
    Troitskaya, V. V.
    Kravchenko, S. K.
    Gabeeva, N. G.
    Kulikov, S. M.
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2015, 60 (02): : 26 - 31
  • [22] The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age
    Mareschal, Sylvain
    Lanic, Helene
    Ruminy, Philippe
    Bastard, Christian
    Tilly, Herve
    Jardin, Fabrice
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (12): : 1888 - 1890
  • [23] Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
    Nyman, Heidi
    Jerkeman, Mats
    Karjalainen-Lindsberg, Marja-Liisa
    Banham, Alison H.
    Leppa, Sirpa
    MODERN PATHOLOGY, 2009, 22 (08) : 1094 - 1101
  • [24] Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
    Dunleavy, Kieron
    Erdmann, Tabea
    Lenz, Georg
    CANCER TREATMENT REVIEWS, 2018, 65 : 41 - 46
  • [25] Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma
    Tanaka, Hiroaki
    Kaneko, Naoki
    Sakagami, Hideki
    Matsuya, Takahiro
    Hiramoto, Masashi
    Yamanaka, Yosuke
    Mori, Masamichi
    Koshio, Hiroyuki
    Hirano, Masaaki
    Takeuchi, Masahiro
    LEUKEMIA RESEARCH, 2020, 88
  • [26] Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma
    Sweetenham, John W.
    CURRENT OPINION IN HEMATOLOGY, 2011, 18 (04) : 288 - 292
  • [27] Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma
    Wei, Yongqiang
    Wei, Xiaolei
    Huang, Weimin
    Song, Jialin
    Zheng, Jingxia
    Zeng, Hong
    Liu, Jianbo
    Zhan, Minglang
    Wei, Qi
    Feng, Ru
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (05) : 681 - 685
  • [28] The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
    Wu, Jianbo
    Meng, Fuqing
    Ran, Danyang
    Song, Yalong
    Dang, Yunkun
    Lai, Fan
    Yang, Longyan
    Deng, Mi
    Song, Yuqin
    Zhu, Jun
    METABOLITES, 2023, 13 (06)
  • [29] Clinical features of diffuse large B-cell lymphoma with polyploidy
    Shimono, Joji
    Miyoshi, Hiroaki
    Seto, Masao
    Teshima, Takanori
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2017, 67 (01) : 17 - 23
  • [30] Primary breast diffuse large B-cell lymphoma shows an activated B-cell-like phenotype
    Li, Dan
    Deng, Jing
    He, Hong
    Bu, Youquan
    Peng, Fengxiang
    Tang, Xuefeng
    Wang, Bin
    Lei, Yang
    Zhang, Hongzhi
    Xie, Peng
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2012, 16 (05) : 335 - 343